Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/25511| Title: | Rituximab : a novel treatment for Pemphigus in Malta |
| Authors: | Boffa, Michelle-Marie Mintoff, Dillon Mercieca, Liam Cassar, David Cauchi, Suzanne Boffa, Michael J. Scerri, Lawrence |
| Keywords: | Pemphigus -- Pathophysiology Pemphigus -- Treatment Rituximab Immune response -- Regulation Biological response modifiers |
| Issue Date: | 2017-12 |
| Publisher: | University of Malta. Medical School |
| Citation: | Boffa, M., Mintoff, D., Mercieca, L., Cassar, D., Cauchi, S., Boffa, M. J., & Scerri, L. (2017). Rituximab : a novel treatment for Pemphigus in Malta. Malta Medical School Gazette, 1(4), 15-22. |
| Abstract: | Until recently, the main treatment for pemphigus has been systemic corticosteroids, usually administered at high doses with consequent side-effects. Lately, the biological agent rituximab has been introduced as an effective treatment for this condition. This article describes seven cases of pemphigus successfully treated with rituximab in Malta and discusses the benefits and drawbacks of this novel treatment modality. |
| URI: | https://www.um.edu.mt/library/oar//handle/123456789/25511 |
| Appears in Collections: | MMSG, Volume 1, Issue 4 MMSG, Volume 1, Issue 4 Scholarly Works - FacM&SMed Scholarly Works - FacM&SPsy |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| MMSG 1-4 - A3.pdf | 1.32 MB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.